Analysis of Number Needed to Treat and Cost of Platelet Glycoprotein IIb/IIIa Inhibitors in Percutaneous Coronary Interventions and Acute Coronary Syndromes

Author(s):  
Dawn M. Bell
Sign in / Sign up

Export Citation Format

Share Document